DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Entocort EC (Budesonide) - Published Studies

 
 



Entocort EC Related Published Studies

Well-designed clinical trials related to Entocort EC (Budesonide)

Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis. [2015]

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies. [2015]

Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. [2013]

Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler(R) in Japanese Patients with Asthma: A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study. [2012.01.01]

Abatacept for Crohn's disease and ulcerative colitis. [2012]

AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD. [2012]

Budesonide/Formoterol Pressurized Metered-Dose Inhaler versus Budesonide: A Randomized Controlled Trial in Black Patients with Asthma. [2011.12.01]

A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain. [2011.10]

Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis. [2011.10]

Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial. [2011.09]

Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. [2011.08]

Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. [2011.07]

Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting. [2011.07]

Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. [2011.05]

3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial. [2011.04]

Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide. [2011.04]

Budesonide quantification by HPLC coupled to atmospheric pressure photoionization (APPI) tandem mass spectrometry. Application to a comparative systemic bioavailability of two budesonide formulations in healthy volunteers. [2011.02.01]

Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease. [2011.02]

Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD. [2011.02]

Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules. [2011.01]

Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology. [2010.11]

Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. [2010.11]

Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. [2010.10]

Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. [2010.10]

Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma. [2010.09]

Paradoxical trough effects of triple therapy with budesonide/formoterol and tiotropium bromide on pulmonary function outcomes in COPD. [2010.09]

Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study. [2010.09]

Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy. [2010.09]

Budesonide versus placebo in high-risk population with screen-detected lung nodules: Rationale, design and methodology. [2010.08.16]

Budesonide is Effective in Adolescent and Adult Patients With Active Eosinophilic Esophagitis. [2010.08.01]

Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis. [2010.08]

Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. [2010.08]

Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study. [2010.08]

Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX(R) 9 mg extended-release tablets in patients with active left-sided ulcerative colitis. [2010.06]

Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. [2010.05.28]

Ketotifen versus inhaled budesonide for controlling childhood asthma. [2010.05]

Aerosolized L-epinephrine vs budesonide for post extubation stridor: a randomized controlled trial. [2010.04.07]

A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants. [2010.04]

Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma. [2010.03]

Effects of budesonide and fluticasone propionate in pediatric asthma patients. [2010.02]

Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. [2010.02]

Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma study. [2010.02]

Clinical assessment of levocetirizine and budesonide in treatment of persistent allergic rhinitis regarding to symptom severity. [2010.02]

Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma. [2010.01]

The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter. [2010.01]

Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study. [2010]

Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study. [2010]

Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial. [2010]

Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. [2010]

The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. [2009.12]

Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study. [2009.12]

Airway and systemic effects of soluble and suspension formulations of nebulized budesonide in asthmatic children. [2009.11]

The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. [2009.10.31]

Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. [2009.10.15]

Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma. [2009.10]

An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice. [2009.09.19]

Aerosolized L epinephrine vs Budesonide for Postextubation Stridor A Randomized Controlled Trial. [2009.09.03]

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma. [2009.09.01]

[Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation] [2009.09]

An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice. [2009.09]

Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. [2009.08]

Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulations. [2009.07]

Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing. [2009.07]

Budesonide improves decreased airway conductance in infants with respiratory symptoms. [2009.07]

Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: a randomized placebo-controlled trial. [2009.07]

Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. [2009.06]

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. [2009.05]

Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. [2009.05]

High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. [2009.04]

Effect of formoterol with or without budesonide in repeated low-dose allergen challenge. [2009.04]

The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis. [2009.03]

Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. [2009.03]

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. [2009.02.19]

A proof-of-concept study to evaluate the antiinflammatory effects of a novel soluble cyclodextrin formulation of nebulized budesonide in patients with mild to moderate asthma. [2009.02]

Budesonide for maintenance of remission in Crohn's disease. [2009.01.21]

Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma. [2009.01.05]

Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. [2009.01]

Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. [2009.01]

Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. [2009]

Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*. [2008.12]

Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole. [2008.11.15]

Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. [2008.11]

Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. [2008.11]

Effects of time, albuterol, and budesonide on the shape of the flow-volume loop in children with asthma. [2008.10]

Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. [2008.10]

Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults. [2008.10]

A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma. [2008.10]

Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. [2008.09]

Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. [2008.09]

Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. [2008.09]

Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma. [2008.08.22]

Oral Budesonide for Maintenance Treatment of Collagenous Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial. [2008.08.07]

[Efficacy and safety of budesonide inhalation suspension nebulization by mesh nebulizer in Japanese infants and young children with bronchial asthma in 12-week, randomised, open study] [2008.08]

Atomization inhalation of terbutaline and budesonide efficiently improved immunity and lung function of AECOPD patients. [2008.08]

Budesonide for induction of remission in Crohn's disease. [2008.07.16]

Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. [2008.07]

Evidence of the in vivo esterification of budesonide in human airways. [2008.07]

Effect of disease duration on dose-response of inhaled budesonide in asthma. [2008.07]

Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. [2008.06]

Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]

Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. [2008.05]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017